PROTEIN AND PEPTIDE LETTERS
Scope & Guideline
Advancing molecular insights through protein and peptide research.
Introduction
Aims and Scopes
- Protein Structure and Function:
The journal publishes studies that explore the structural properties of proteins, their dynamics, and how these attributes relate to their biological functions. - Peptide Therapeutics and Drug Development:
Research on bioactive peptides, their mechanisms of action, and their potential applications in drug development and therapeutic interventions is a core focus. - Proteomics and Mass Spectrometry:
Innovative proteomic techniques, including mass spectrometry, are frequently featured, highlighting advancements in protein analysis and biomarker discovery. - Molecular Biology and Genetic Engineering:
The journal includes articles on the molecular mechanisms underlying gene expression, protein synthesis, and the use of genetic engineering techniques to modify proteins and peptides. - Biotechnology and Bioengineering Applications:
Studies that apply protein and peptide research to biotechnological processes, including enzyme engineering and the development of novel biomaterials, are emphasized. - Cancer Biology and Therapeutics:
There is a significant focus on the roles of proteins and peptides in cancer biology, including studies on oncogenic pathways and potential therapeutic targets. - Immunology and Vaccine Development:
Research related to the immunogenicity of proteins and peptides, including their use in vaccine development and immune response modulation, is also a key area of interest.
Trending and Emerging
- Protein-Protein Interactions and Networks:
There is a rising interest in studying protein-protein interactions and their implications in cellular networks, which is crucial for understanding complex biological processes. - Bioinformatics and Computational Biology:
The integration of bioinformatics tools to analyze protein structures, functions, and interactions is becoming more prevalent, facilitating deeper insights into protein science. - Peptide-Based Nanocarriers and Drug Delivery Systems:
Research on utilizing peptides as nanocarriers for drug delivery is on the rise, showcasing innovative approaches to enhance the bioavailability and efficacy of therapeutics. - Targeted Cancer Therapy:
A growing number of studies focus on the development of targeted therapies using engineered proteins and peptides, particularly in oncology, reflecting a shift towards personalized medicine. - Microbiome and Host Interactions:
Emerging research exploring the role of proteins and peptides in microbiome interactions and their effects on host health is gaining prominence, indicating a broader understanding of health and disease. - CRISPR and Gene Editing Technologies:
The applications of CRISPR and other gene-editing technologies in protein engineering and therapeutic development are increasingly being featured, highlighting their revolutionary impact on biotechnology.
Declining or Waning
- Traditional Enzymology:
Research focusing solely on classical enzymatic mechanisms without broader implications for protein engineering or therapeutic applications is waning, as interest shifts towards more applied and innovative approaches. - Basic Biochemical Pathways:
While foundational studies are essential, there is a noticeable decline in the publication of papers that exclusively describe basic metabolic pathways without integrating into larger biological or therapeutic contexts. - Agricultural Proteomics:
The application of proteomics specifically in agricultural settings, such as crop improvement, seems to be less emphasized in recent issues, indicating a shift towards more clinical and biomedical applications. - In Vitro Studies without Clinical Relevance:
Studies that focus solely on in vitro experiments without clear pathways to clinical application or relevance are becoming less common, as the journal seeks more translational research. - Historical Reviews on Protein Functions:
The journal appears to be moving away from historical reviews that do not incorporate current research trends or implications, favoring more forward-looking studies.
Similar Journals
BMC BIOTECHNOLOGY
Exploring the Future of Genetic EngineeringBMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Bridging Molecular Biology and BioinformaticsPROTEINS - STRUCTURE FUNCTION AND BIOINFORMATICS, published by WILEY, is a leading journal in the fields of biochemistry, molecular biology, and structural biology, recognized for its significant contribution to protein research since its inception in 1986. With its impressive rankings in the Q1 category for Biochemistry and Q2 for both Molecular Biology and Structural Biology in 2023, the journal serves as an essential resource for researchers and professionals seeking to explore the intricate relationships between protein structures and their functions. The journal, based in the United States, operates without an Open Access model, ensuring a curated selection of high-quality peer-reviewed articles that drive innovation and collaboration in the scientific community. Engaging with the robust content of PROTEINS not only bolsters academic scholarship but also opens avenues for groundbreaking discoveries that are pivotal in the advancing field of bioinformatics.
CURRENT PROTEIN & PEPTIDE SCIENCE
Advancing the Frontiers of Protein and Peptide ResearchCURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.
Doklady Biochemistry and Biophysics
Connecting Researchers through Innovative Biochemistry and Biophysics InsightsDoklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.
MOLECULAR & CELLULAR PROTEOMICS
Connecting researchers with cutting-edge proteomic discoveries.MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.
JOURNAL OF BIOLOGICAL CHEMISTRY
Advancing the Frontiers of Biochemical ResearchJOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Advancing the frontiers of biochemistry and biophysics.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.
Current Proteomics
Fostering Collaboration in Proteomics ExcellenceCurrent Proteomics is a distinguished journal dedicated to the dynamic field of proteomics, offering researchers and professionals a platform to disseminate innovative findings and comprehensive reviews. Published by Bentham Science Publishers Ltd, this journal caters to a global audience and serves as an essential resource for students, academics, and industry experts interested in advances in biochemistry and molecular biology. With an ISSN of 1570-1646 and an E-ISSN of 1875-6247, the journal has established itself in various research categories, achieving a Q4 ranking in both Biochemistry and Molecular Biology as of 2023. While the impact factor and H-index data are not specified, its Scopus ranking reflects a competitive position in its fields, with percentiles in the 12th to 16th range. Although not an open-access journal, Current Proteomics is vital for fostering ongoing dialogue and collaboration in proteomic research, encouraging contributions that explore cutting-edge methodologies and applications. Researchers are invited to share their insights and contribute to this evolving discipline, thus enhancing the collective understanding of proteomics within the scientific community.
PROTEIN EXPRESSION AND PURIFICATION
Navigating the Complexities of Protein BiochemistryPROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Transforming Insights into Proteomic DiscoveriesBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, published by Elsevier, is a prestigious academic journal that serves as a vital resource for researchers, professionals, and students in the fields of biochemistry, biophysics, and proteomics. With an ISSN of 1570-9639 and an E-ISSN of 1878-1454, this journal features high-impact research articles aimed at advancing our understanding of protein structure, function, and interactions, contributing significantly to both theoretical and applied sciences. Recognized for its quality, it proudly holds a Q1 ranking in Analytical Chemistry and Biophysics, and Q2 in Biochemistry for 2023, alongside notable Scopus rankings that reflect its influence in the realm of molecular biology. The journal's commitment to disseminating essential findings supports the ongoing evolution of proteomic sciences and encourages collaborative discourse among the global scientific community. For aspiring authors, the journal offers open access options, enabling broad visibility of their work. Join the conversation in this dynamic field and contribute to shaping the future of protein research!